HomeCompareHTGM vs PLD

HTGM vs PLD: Dividend Comparison 2026

HTGM yields 416.67% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HTGM wins by $15440.95M in total portfolio value
10 years
HTGM
HTGM
● Live price
416.67%
Share price
$0.48
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15446.85M
Annual income
$10,492,957,272.45
Full HTGM calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — HTGM vs PLD

📍 HTGM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTGMPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTGM + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTGM pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTGM
Annual income on $10K today (after 15% tax)
$35,416.67/yr
After 10yr DRIP, annual income (after tax)
$8,919,013,681.58/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, HTGM beats the other by $8,914,975,565.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTGM + PLD for your $10,000?

HTGM: 50%PLD: 50%
100% PLD50/50100% HTGM
Portfolio after 10yr
$7726.38M
Annual income
$5,248,853,998.81/yr
Blended yield
67.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

HTGM
Analyst Ratings
8
Buy
Consensus: Buy
Price Target
$0.17
-65.3% upside vs current
Range: $0.17 — $0.17
Altman Z
-35.3
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTGM buys
0
PLD buys
0
No recent congressional trades found for HTGM or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTGMPLD
Forward yield416.67%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$15446.85M$5.91M
Annual income after 10y$10,492,957,272.45$4,750,725.19
Total dividends collected$14996.03M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$0.17$136.00

Year-by-year: HTGM vs PLD ($10,000, DRIP)

YearHTGM PortfolioHTGM Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$52,367$41,666.67$11,241$540.96+$41.1KHTGM
2$259,952$203,920.04$13,019$991.13+$246.9KHTGM
3$1,224,201$946,051.97$15,801$1,870.97+$1.21MHTGM
4$5,473,698$4,163,802.84$20,609$3,701.21+$5.45MHTGM
5$23,256,265$17,399,408.07$29,919$7,867.97+$23.23MHTGM
6$93,973,351$69,089,147.58$50,631$18,617.74+$93.92MHTGM
7$361,461,534$260,910,048.59$105,528$51,352.20+$361.36MHTGM
8$1,324,680,829$937,916,987.81$287,364$174,449.42+$1324.39MHTGM
9$4,629,809,751$3,212,401,263.77$1,081,760$774,280.77+$4628.73MHTGM
10$15,446,853,706$10,492,957,272.45$5,908,209$4,750,725.19+$15440.95MHTGM

HTGM vs PLD: Complete Analysis 2026

HTGMStock

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

Full HTGM Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this HTGM vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTGM vs SCHDHTGM vs JEPIHTGM vs OHTGM vs KOHTGM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.